CIRC(01763): The exhale diagnostics product has been awarded the national pharmaceutical industry single event championship.
China Tongfu (01763) issued an announcement that recently, its subsidiary, Shenzhen Zhonghe Haideweibio Technology Co., Ltd...
CIRC (01763) announced that its subsidiary, Shenzhen Zhonghe Hede Wei Biotechnology Co., Ltd., has recently been selected as a national-level manufacturing enterprise and awarded the "Pharmaceutical Industry Champion" title, thanks to its core product "Urea [13C/14C] Breath Test Kit."
CIRC has always focused on the urea [13C] and [14C] breath test diagnostic segment in the medical isotope application field. The urea [13C] and [14C] breath test products produced by the company are used to detect Helicobacter pylori, with coverage of over 20,000 domestic end customers and sales to 90 countries and regions. The market share has consistently ranked at the forefront of the industry for many years.
Related Articles

US Stock Market Move | BEIGENE (ONC.US) rose more than 3% with third-quarter revenue breaking 10 billion and raising its 2025 performance guidance.

US Stock Market Move | SunocoCorp (SUNC.US) debuts on the US stock market with a lower opening stock price.

US Stock Market Move | Bitcoin concept stocks fall across the board, Robinhood (HOOD.US) falls more than 9%
US Stock Market Move | BEIGENE (ONC.US) rose more than 3% with third-quarter revenue breaking 10 billion and raising its 2025 performance guidance.

US Stock Market Move | SunocoCorp (SUNC.US) debuts on the US stock market with a lower opening stock price.

US Stock Market Move | Bitcoin concept stocks fall across the board, Robinhood (HOOD.US) falls more than 9%

RECOMMEND

SERES Faces Market Test in Hong Kong: Shares Open Below Issue Price Despite HK$220 Billion Market Valuation
06/11/2025

Copper Prices Surge While Former “Copper King” Who Outpaced Huawei and Tencent Falls into Decline
06/11/2025

National Energy Administration Reports New-Type Energy Storage Capacity Exceeds 100 Million Kilowatts by End‑September
06/11/2025


